Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Karampli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Cost of Active Systemic Lupus Erythematosus in Greece Results From the Lycos StudyK Athanasakis, E Karampli, D Psomali, et al.
Community Dental Health|November 5, 2010
Social determinants of dental health services utilisation of Greek adultsE Pavi, E Karampli, D Zavras, et al.
Hippokratia|October 23, 2014
Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to GreeceE Karampli, K Souliotis, N Polyzos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Challenges and Opportunities in The Management of Chronic Diseases During The Economic Crisis In Greece: A Qualitative ApproachV Tsiantou, K Mylona, E Karampli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Physicians Estimation Regarding The Impact Of Recession on Patient Adherence To Treatment In Diabetes Type 2 In GreeceV Tsiantou, D Zavras, E Karampli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Is the rule of halves applicable in Diabetes Type 2? Evidence from GreeceV Tsiantou, E Karampli, D Zavras, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Greece: A Cost-Effectiveness and Cost-Utility AnalysisK Athanasakis, E Karampli, M Ollandezos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Access To Orphan Drugs In Greece During Economic CrisisV Tsiantou, K Mylona, E Karampli, et al.
Lupus|April 9, 2016
Clinical and financial burden of active lupus in Greece: a nationwide studyG Bertsias, E Karampli, P Sidiropoulos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Cost of Active Systemic Lupus Erythematosus in Greece Results From the Lycos StudyK Athanasakis, E Karampli, D Psomali, et al.
Community Dental Health|November 5, 2010
Social determinants of dental health services utilisation of Greek adultsE Pavi, E Karampli, D Zavras, et al.
Hippokratia|October 23, 2014
Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to GreeceE Karampli, K Souliotis, N Polyzos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Challenges and Opportunities in The Management of Chronic Diseases During The Economic Crisis In Greece: A Qualitative ApproachV Tsiantou, K Mylona, E Karampli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Physicians Estimation Regarding The Impact Of Recession on Patient Adherence To Treatment In Diabetes Type 2 In GreeceV Tsiantou, D Zavras, E Karampli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Is the rule of halves applicable in Diabetes Type 2? Evidence from GreeceV Tsiantou, E Karampli, D Zavras, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Greece: A Cost-Effectiveness and Cost-Utility AnalysisK Athanasakis, E Karampli, M Ollandezos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Access To Orphan Drugs In Greece During Economic CrisisV Tsiantou, K Mylona, E Karampli, et al.
Lupus|April 9, 2016
Clinical and financial burden of active lupus in Greece: a nationwide studyG Bertsias, E Karampli, P Sidiropoulos, et al.
Pageof 1